- Home
- WLKP vs MDXG Comparison
WLKP vs MDXG Comparison
Compare WLKP & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- MDXG
- Stock Information
- Founded
- WLKP 2014
- MDXG 2006
- Country
- WLKP United States
- MDXG United States
- Employees
- WLKP N/A
- MDXG N/A
- Industry
- WLKP Major Chemicals
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- WLKP Industrials
- MDXG Health Care
- Exchange
- WLKP Nasdaq
- MDXG Nasdaq
- Market Cap
- WLKP 833.7M
- MDXG 999.9M
- IPO Year
- WLKP 2014
- MDXG N/A
- Fundamental
- Price
- WLKP $22.38
- MDXG $6.19
- Analyst Decision
- WLKP
- MDXG Strong Buy
- Analyst Count
- WLKP 0
- MDXG 2
- Target Price
- WLKP N/A
- MDXG $12.50
- AVG Volume (30 Days)
- WLKP 34.1K
- MDXG 614.4K
- Earning Date
- WLKP 08-05-2025
- MDXG 07-30-2025
- Dividend Yield
- WLKP 8.48%
- MDXG N/A
- EPS Growth
- WLKP N/A
- MDXG N/A
- EPS
- WLKP 1.49
- MDXG 0.27
- Revenue
- WLKP $1,088,852,000.00
- MDXG $352,375,000.00
- Revenue This Year
- WLKP $8.90
- MDXG $9.55
- Revenue Next Year
- WLKP $6.87
- MDXG $11.43
- P/E Ratio
- WLKP $14.93
- MDXG $22.93
- Revenue Growth
- WLKP N/A
- MDXG 5.34
- 52 Week Low
- WLKP $21.19
- MDXG $5.47
- 52 Week High
- WLKP $25.04
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- WLKP 53.50
- MDXG 49.01
- Support Level
- WLKP $21.96
- MDXG $5.86
- Resistance Level
- WLKP $22.48
- MDXG $6.42
- Average True Range (ATR)
- WLKP 0.30
- MDXG 0.22
- MACD
- WLKP 0.06
- MDXG 0.05
- Stochastic Oscillator
- WLKP 83.97
- MDXG 69.84
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.